 Javier Valle
Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 33 | 2023 | 549 | 6.660 |
Why?
| | Coronary Artery Disease | 21 | 2023 | 749 | 3.760 |
Why?
| | Coronary Angiography | 15 | 2023 | 328 | 2.280 |
Why?
| | Peripheral Arterial Disease | 7 | 2022 | 507 | 1.700 |
Why?
| | Myocardial Infarction | 15 | 2022 | 1210 | 1.700 |
Why?
| | Angioplasty, Balloon | 5 | 2022 | 94 | 1.640 |
Why?
| | Registries | 16 | 2023 | 2406 | 1.620 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2022 | 154 | 1.570 |
Why?
| | ST Elevation Myocardial Infarction | 3 | 2019 | 64 | 1.520 |
Why?
| | Cardiovascular Agents | 3 | 2023 | 166 | 1.470 |
Why?
| | Coronary Artery Bypass | 7 | 2023 | 268 | 1.330 |
Why?
| | Veterans Health | 8 | 2020 | 190 | 1.310 |
Why?
| | Vascular Calcification | 7 | 2022 | 110 | 1.310 |
Why?
| | Femoral Artery | 7 | 2022 | 190 | 1.260 |
Why?
| | Veterans | 10 | 2023 | 1635 | 1.250 |
Why?
| | United States Department of Veterans Affairs | 18 | 2021 | 778 | 1.120 |
Why?
| | Coronary Vessels | 4 | 2020 | 246 | 1.070 |
Why?
| | Ischemia | 4 | 2019 | 422 | 1.020 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2019 | 499 | 1.010 |
Why?
| | Aortic Valve Stenosis | 5 | 2022 | 256 | 0.980 |
Why?
| | Myocardial Revascularization | 5 | 2019 | 85 | 0.980 |
Why?
| | Treatment Outcome | 37 | 2023 | 11772 | 0.960 |
Why?
| | Atherectomy | 7 | 2022 | 37 | 0.960 |
Why?
| | Time-to-Treatment | 2 | 2019 | 251 | 0.960 |
Why?
| | Surgical Procedures, Operative | 6 | 2018 | 271 | 0.940 |
Why?
| | Endovascular Procedures | 4 | 2019 | 390 | 0.900 |
Why?
| | Coronary Occlusion | 2 | 2023 | 20 | 0.890 |
Why?
| | Preoperative Care | 3 | 2018 | 380 | 0.870 |
Why?
| | Hospital Mortality | 8 | 2021 | 1038 | 0.840 |
Why?
| | Lower Extremity | 3 | 2018 | 445 | 0.840 |
Why?
| | Atrial Flutter | 1 | 2024 | 47 | 0.800 |
Why?
| | Angioplasty, Balloon, Coronary | 3 | 2013 | 156 | 0.780 |
Why?
| | Risk Factors | 29 | 2023 | 10885 | 0.770 |
Why?
| | Hospitals, Veterans | 3 | 2020 | 258 | 0.760 |
Why?
| | United States | 34 | 2021 | 16098 | 0.760 |
Why?
| | Catheterization, Peripheral | 3 | 2021 | 120 | 0.750 |
Why?
| | Embolic Protection Devices | 2 | 2021 | 12 | 0.750 |
Why?
| | Factor Xa Inhibitors | 1 | 2024 | 194 | 0.720 |
Why?
| | Pyridones | 1 | 2024 | 209 | 0.720 |
Why?
| | Non-ST Elevated Myocardial Infarction | 2 | 2019 | 26 | 0.700 |
Why?
| | Technology Transfer | 1 | 2021 | 9 | 0.690 |
Why?
| | Aged | 39 | 2022 | 26153 | 0.690 |
Why?
| | Radial Artery | 3 | 2021 | 75 | 0.690 |
Why?
| | Hemorrhage | 6 | 2024 | 822 | 0.680 |
Why?
| | Aspirin | 3 | 2020 | 406 | 0.670 |
Why?
| | Time Factors | 23 | 2020 | 7123 | 0.660 |
Why?
| | Coated Materials, Biocompatible | 4 | 2022 | 65 | 0.620 |
Why?
| | Pyrazoles | 1 | 2024 | 517 | 0.620 |
Why?
| | Heart Arrest | 3 | 2019 | 410 | 0.580 |
Why?
| | Saphenous Vein | 1 | 2019 | 37 | 0.580 |
Why?
| | Humans | 74 | 2024 | 145474 | 0.580 |
Why?
| | Graft Occlusion, Vascular | 1 | 2019 | 40 | 0.570 |
Why?
| | Risk Assessment | 16 | 2022 | 3747 | 0.570 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2021 | 198 | 0.570 |
Why?
| | Centralized Hospital Services | 1 | 2018 | 6 | 0.570 |
Why?
| | Atrial Fibrillation | 1 | 2024 | 558 | 0.530 |
Why?
| | Arm | 1 | 2018 | 110 | 0.530 |
Why?
| | Transportation of Patients | 1 | 2018 | 65 | 0.530 |
Why?
| | Middle Aged | 34 | 2021 | 36215 | 0.530 |
Why?
| | Peripheral Vascular Diseases | 1 | 2018 | 104 | 0.530 |
Why?
| | Male | 47 | 2024 | 72842 | 0.520 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2017 | 2 | 0.520 |
Why?
| | Inferior Wall Myocardial Infarction | 1 | 2017 | 2 | 0.520 |
Why?
| | Fibrinolytic Agents | 2 | 2018 | 297 | 0.520 |
Why?
| | Papillary Muscles | 1 | 2017 | 13 | 0.520 |
Why?
| | Tibial Arteries | 1 | 2017 | 13 | 0.500 |
Why?
| | Endarterectomy, Carotid | 1 | 2017 | 64 | 0.500 |
Why?
| | Atherectomy, Coronary | 3 | 2022 | 10 | 0.500 |
Why?
| | Renal Artery Obstruction | 1 | 2017 | 30 | 0.500 |
Why?
| | Healthcare Disparities | 3 | 2018 | 735 | 0.500 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 285 | 0.490 |
Why?
| | Renal Artery | 1 | 2017 | 43 | 0.490 |
Why?
| | Popliteal Artery | 3 | 2022 | 62 | 0.480 |
Why?
| | Disease Management | 2 | 2019 | 653 | 0.480 |
Why?
| | Carotid Stenosis | 1 | 2017 | 107 | 0.470 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 443 | 0.470 |
Why?
| | Female | 44 | 2024 | 78844 | 0.460 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2016 | 115 | 0.450 |
Why?
| | Decision Support Systems, Clinical | 1 | 2019 | 272 | 0.450 |
Why?
| | Exercise Test | 1 | 2018 | 630 | 0.440 |
Why?
| | Ticlopidine | 1 | 2015 | 52 | 0.440 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 229 | 0.430 |
Why?
| | Heart Diseases | 1 | 2018 | 341 | 0.430 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 252 | 0.430 |
Why?
| | Stents | 8 | 2020 | 564 | 0.410 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 558 | 0.410 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1371 | 0.410 |
Why?
| | Obesity | 2 | 2019 | 3116 | 0.400 |
Why?
| | Contrast Media | 1 | 2017 | 497 | 0.400 |
Why?
| | Anticoagulants | 2 | 2016 | 748 | 0.400 |
Why?
| | Postoperative Complications | 6 | 2019 | 2970 | 0.390 |
Why?
| | Heart Conduction System | 2 | 2013 | 96 | 0.390 |
Why?
| | Adrenergic Antagonists | 1 | 2013 | 5 | 0.390 |
Why?
| | Aged, 80 and over | 12 | 2024 | 8333 | 0.370 |
Why?
| | Mental Health | 1 | 2019 | 793 | 0.360 |
Why?
| | Odds Ratio | 7 | 2021 | 1082 | 0.350 |
Why?
| | Stroke | 5 | 2022 | 1270 | 0.340 |
Why?
| | Cohort Studies | 9 | 2021 | 6013 | 0.340 |
Why?
| | Thromboembolism | 2 | 2024 | 129 | 0.320 |
Why?
| | Patient Discharge | 2 | 2016 | 992 | 0.310 |
Why?
| | Aortic Valve | 4 | 2022 | 364 | 0.310 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 1097 | 0.310 |
Why?
| | Health Services Accessibility | 1 | 2018 | 1101 | 0.310 |
Why?
| | Vascular Access Devices | 2 | 2020 | 30 | 0.300 |
Why?
| | Mental Disorders | 1 | 2019 | 1163 | 0.300 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 875 | 0.290 |
Why?
| | Inpatients | 1 | 2013 | 553 | 0.280 |
Why?
| | Retrospective Studies | 20 | 2022 | 17291 | 0.270 |
Why?
| | Vascular Patency | 4 | 2020 | 121 | 0.260 |
Why?
| | Coronary Stenosis | 2 | 2017 | 40 | 0.250 |
Why?
| | Acute Coronary Syndrome | 2 | 2022 | 297 | 0.250 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 1044 | 0.250 |
Why?
| | Follow-Up Studies | 7 | 2021 | 5423 | 0.240 |
Why?
| | Arterial Occlusive Diseases | 2 | 2018 | 90 | 0.240 |
Why?
| | Logistic Models | 5 | 2017 | 2134 | 0.230 |
Why?
| | Heart Failure | 1 | 2018 | 2326 | 0.220 |
Why?
| | Survival Rate | 6 | 2021 | 2090 | 0.210 |
Why?
| | Limb Salvage | 3 | 2019 | 73 | 0.210 |
Why?
| | Prognosis | 6 | 2021 | 4316 | 0.210 |
Why?
| | Comorbidity | 3 | 2019 | 1661 | 0.210 |
Why?
| | Propensity Score | 3 | 2021 | 377 | 0.190 |
Why?
| | Incidence | 7 | 2019 | 2923 | 0.190 |
Why?
| | Predictive Value of Tests | 5 | 2018 | 2121 | 0.180 |
Why?
| | Iliac Artery | 2 | 2020 | 55 | 0.170 |
Why?
| | Practice Guidelines as Topic | 3 | 2019 | 1581 | 0.170 |
Why?
| | Paclitaxel | 1 | 2022 | 257 | 0.170 |
Why?
| | Cardiovascular Diseases | 3 | 2020 | 2187 | 0.170 |
Why?
| | Punctures | 2 | 2018 | 41 | 0.170 |
Why?
| | Troponin | 1 | 2021 | 50 | 0.160 |
Why?
| | Patient Readmission | 5 | 2019 | 769 | 0.160 |
Why?
| | Heart Failure, Systolic | 1 | 2021 | 26 | 0.160 |
Why?
| | Hospitals, Community | 1 | 2020 | 67 | 0.150 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1547 | 0.150 |
Why?
| | Assisted Circulation | 1 | 2019 | 26 | 0.150 |
Why?
| | Chi-Square Distribution | 2 | 2017 | 527 | 0.150 |
Why?
| | Lithotripsy | 1 | 2020 | 49 | 0.150 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 52 | 0.150 |
Why?
| | Access to Information | 1 | 2019 | 47 | 0.150 |
Why?
| | Prostate | 1 | 2020 | 158 | 0.150 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2019 | 19 | 0.140 |
Why?
| | Endocrinologists | 1 | 2018 | 12 | 0.140 |
Why?
| | Chronic Disease | 2 | 2023 | 1808 | 0.140 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 63 | 0.140 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 202 | 0.140 |
Why?
| | Postoperative Hemorrhage | 1 | 2020 | 105 | 0.140 |
Why?
| | Atrioventricular Block | 1 | 2019 | 44 | 0.140 |
Why?
| | Thrombosis | 1 | 2022 | 400 | 0.140 |
Why?
| | Office Visits | 1 | 2018 | 92 | 0.140 |
Why?
| | Heart Block | 1 | 2018 | 41 | 0.130 |
Why?
| | Laser Therapy | 1 | 2019 | 144 | 0.130 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2018 | 79 | 0.130 |
Why?
| | Stroke Volume | 1 | 2021 | 654 | 0.130 |
Why?
| | Carotid Artery, Internal | 1 | 2017 | 45 | 0.130 |
Why?
| | Quality Improvement | 2 | 2019 | 1295 | 0.130 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2017 | 37 | 0.130 |
Why?
| | Ventricular Function, Left | 1 | 2021 | 542 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 5904 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 2 | 2018 | 303 | 0.130 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 345 | 0.130 |
Why?
| | American Heart Association | 1 | 2018 | 358 | 0.120 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 68 | 0.120 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 610 | 0.120 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 132 | 0.120 |
Why?
| | Cardiology | 1 | 2019 | 362 | 0.120 |
Why?
| | Clinical Decision-Making | 2 | 2018 | 363 | 0.120 |
Why?
| | Patient Admission | 1 | 2018 | 220 | 0.120 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 129 | 0.120 |
Why?
| | Angiography | 1 | 2017 | 208 | 0.120 |
Why?
| | Angina, Unstable | 1 | 2016 | 83 | 0.120 |
Why?
| | Decision Making | 2 | 2021 | 977 | 0.110 |
Why?
| | Hospitalization | 4 | 2021 | 2460 | 0.110 |
Why?
| | Patient Care Planning | 1 | 2016 | 170 | 0.110 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 519 | 0.110 |
Why?
| | Body Weight | 1 | 2019 | 971 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2016 | 1327 | 0.110 |
Why?
| | Outpatients | 1 | 2018 | 447 | 0.110 |
Why?
| | Cause of Death | 2 | 2019 | 470 | 0.110 |
Why?
| | Electronic Health Records | 2 | 2019 | 1196 | 0.100 |
Why?
| | Prospective Studies | 4 | 2020 | 8057 | 0.100 |
Why?
| | Acute Disease | 1 | 2017 | 1036 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1061 | 0.100 |
Why?
| | Echocardiography | 1 | 2016 | 647 | 0.100 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 338 | 0.100 |
Why?
| | Pacemaker, Artificial | 2 | 2018 | 128 | 0.090 |
Why?
| | Prostatic Neoplasms | 1 | 2020 | 978 | 0.090 |
Why?
| | Recovery of Function | 1 | 2017 | 716 | 0.090 |
Why?
| | Blood Pressure | 1 | 2019 | 1779 | 0.090 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2930 | 0.090 |
Why?
| | Hospitals | 2 | 2019 | 732 | 0.090 |
Why?
| | Michigan | 3 | 2022 | 134 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 1193 | 0.080 |
Why?
| | Overweight | 1 | 2016 | 614 | 0.080 |
Why?
| | Hypertension | 1 | 2019 | 1273 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2953 | 0.080 |
Why?
| | Tunica Intima | 1 | 2010 | 78 | 0.080 |
Why?
| | Carotid Arteries | 1 | 2010 | 208 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2020 | 249 | 0.070 |
Why?
| | Inflammation | 1 | 2020 | 2878 | 0.070 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 98 | 0.070 |
Why?
| | Mortality | 2 | 2020 | 378 | 0.060 |
Why?
| | Body Mass Index | 1 | 2016 | 2445 | 0.060 |
Why?
| | Databases, Factual | 3 | 2019 | 1490 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 1 | 2009 | 355 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2381 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2020 | 2588 | 0.060 |
Why?
| | Defibrillators, Implantable | 1 | 2009 | 382 | 0.050 |
Why?
| | Program Evaluation | 2 | 2017 | 943 | 0.050 |
Why?
| | Prevalence | 2 | 2019 | 2865 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 969 | 0.040 |
Why?
| | Angina Pectoris | 1 | 2020 | 76 | 0.040 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2020 | 88 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 198 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4553 | 0.040 |
Why?
| | Health Facilities | 1 | 2019 | 85 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2019 | 69 | 0.040 |
Why?
| | Heart | 1 | 2022 | 626 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 168 | 0.030 |
Why?
| | California | 1 | 2019 | 471 | 0.030 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 29 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 351 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1266 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 336 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 477 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1138 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 280 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 283 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2017 | 330 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 360 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2020 | 2062 | 0.030 |
Why?
| | Glucose | 1 | 2020 | 1048 | 0.030 |
Why?
| | Patient Selection | 1 | 2018 | 738 | 0.030 |
Why?
| | Coronary Disease | 1 | 2016 | 381 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1707 | 0.020 |
Why?
| | Critical Illness | 1 | 2019 | 900 | 0.020 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 394 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3623 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2016 | 586 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3413 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2020 | 1399 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 322 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 785 | 0.020 |
Why?
| | Pulmonary Embolism | 1 | 2009 | 241 | 0.010 |
Why?
| | Academic Medical Centers | 1 | 2009 | 554 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1747 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 14218 | 0.010 |
Why?
| | Adult | 2 | 2018 | 40777 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22529 | 0.010 |
Why?
|
|
Valle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|